This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses)
Clinical trial NCT03165227 · COMPLETED
Trial details
- NCT number
- NCT03165227
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-17
- Primary completion
- 2019-12-10
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.